Jagsonpal Pharmaceuticals Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 68.82% of Jagsonpal Pharmaceuticals, FIIs hold 2.13%, DIIs hold 1.64% and the public holds 27.40%. Promoter holding fell by 0.24 percentage points from Jun 2026.
Get an alert when Jagsonpal Pharmaceuticals reports results or its shareholding changes. Free account.
Promoters
68.82%
−0.24 pp QoQ
FIIs
2.13%
−0.17 pp QoQ
DIIs
1.64%
+1.02 pp QoQ
Public
27.40%
−0.64 pp QoQ
Jagsonpal Pharmaceuticals shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 68.82% | 2.13% | 1.64% | 27.40% | 26,537 |
| Jun 2026 | 69.06% | 2.30% | 0.62% | 28.04% | 24,181 |
| Mar 2026 | 67.89% | 2.44% | 0.22% | 29.44% | 26,264 |
| Dec 2025 | 67.39% | 2.12% | 0.15% | 30.34% | 24,895 |
| Sep 2025 | 67.54% | 2.12% | 0.08% | 30.25% | 24,653 |
| Jun 2025 | 67.65% | 2.17% | 0.05% | 30.12% | 22,899 |
| Mar 2025 | 67.77% | 2.10% | 0.00% | 30.11% | 21,085 |
| Dec 2024 | 67.82% | 2.10% | 0.00% | 30.10% | 18,471 |
| Sep 2024 | 67.98% | 2.30% | 0.11% | 29.63% | 15,633 |
| Jun 2024 | 68.04% | 1.10% | 0.84% | 30.01% | 15,748 |
| Mar 2024 | 68.09% | 0.73% | 0.84% | 30.33% | 16,282 |
| Dec 2023 | 68.48% | 0.53% | 0.82% | 30.16% | 15,785 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹1.42k cr, the promoter group's 68.82% stake is worth ₹980 cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Jagsonpal Pharmaceuticals shareholding: common questions
What is the promoter holding in Jagsonpal Pharmaceuticals?
Promoters hold 68.82% of Jagsonpal Pharmaceuticals as of Sep 2026. Their stake fell by 0.24 percentage points from Jun 2026.
How much do FIIs hold in Jagsonpal Pharmaceuticals?
Foreign institutional investors (FIIs) held 2.13% of Jagsonpal Pharmaceuticals in Sep 2026, −0.17 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Jagsonpal Pharmaceuticals?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 1.64% of Jagsonpal Pharmaceuticals in Sep 2026, +1.02 pp versus Jun 2026.
Is the promoter holding in Jagsonpal Pharmaceuticals pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Jagsonpal Pharmaceuticals.
How has Jagsonpal Pharmaceuticals's promoter holding changed in the last year?
Promoter holding moved from 67.54% in Sep 2025 to 68.82% in Sep 2026 (+1.28 pp).
How many shareholders does Jagsonpal Pharmaceuticals have?
Jagsonpal Pharmaceuticals had 26,537 shareholders in Sep 2026, compared with 24,181 in Jun 2026.